CGEN · Compugen Ltd
$2.41
+0.00 (+0.00%)
At close · Aug 14
Market Cap
$228.29M
Shares
94.72M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.41
Open$2.40
Day$2.36–2.43
52W close$1.33–3.10
Avg vol 30d261K
Short int2.8M · 3.0% float · 13.0d
Short vol49%
Last earningsAug 3, 2026
DataJan 2020–Aug 2026
Up next
Next earnings call
Nov 3, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+15%
above
Price vs 50-day avg
+7%
above
RSI (14)
54
neutral
MACD trend
Positive
52-week position
61%
mid-range
Momentum
relative strength
1-month return
+2%
trailing
6-month return
+41%
trailing
YTD return
+58%
this year
Relative strength
+27%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+1% holders QoQ · +15 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.97% of float · ▼ -7.0% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
80 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Revenue growth
+161%
Y/Y
Gross margin
87%
expanding
EPS growth
+338%
Y/Y
Free cash flow
$31.3M
Balance sheet
$90.6M
net cash
Quant / Vol
risk profile
Volatility
70%
annualized · 1-yr
Max drawdown
−37%
past year
ATR
4.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+15%
Bullish
Price vs 50-day avg
+7%
Bullish
RSI (14)
54
Neutral
MACD trend
Positive
Bullish
52-week position
61%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+1% holders QoQ · +15 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.97% of float · ▼ -7.0% MoM · 13.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
80 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $2 · 61%
Range high $3
vs 200-day avg +15%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CGEN
this stock
Compugen Ltd
|
$228.29M | +57.5% | +161.1% | — | 3.0% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CGEN | +0.0% | +1.7% | +40.9% | +2.6% | +57.5% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -0.4% | -2.8% | +27.2% | -1.4% | +43.7% |
Key facts
CIK
1119774
CUSIP
M25722105
13F (30d)
76 filings
74 filers
Visit website
Investor relations